SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: burner who wrote (322)11/8/1998 11:23:00 PM
From: Garry K.  Read Replies (1) | Respond to of 572
 
Dan,

I have a feeling Xillix is going to go sideways for some time until 4th quarter results are out, or until some major news release about sales/product development is made. I think a lot of investors have lost patience on this stock in the short term and may return once some momentum has been built with the stock. I guess this may be good for the patient investor who plans to buy on continued dips over the next quarter.

Any opinions? Take care.

Garry

P.S. Still following Novopharm Biotech?



To: burner who wrote (322)11/19/1998 6:09:00 AM
From: Garth Richmond  Read Replies (1) | Respond to of 572
 
Pierre Leduc was on Investors OnLine in early Sept.
The RealVideo is available at:

ram.insinc.ca

I haven't tried it myself...Pierre Leduc comes near the end I think, so you'll have to scroll through it a bit...


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News